Tower Research Capital LLC (Trc) Uro Gen Pharma Ltd. Transaction History

Tower Research Capital LLC (Trc)

$4.07 Billion
Q1 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 187 shares of URGN stock, worth $2,969. This represents 0.0% of its overall portfolio holdings.

Number of Shares

187

Previous 1,691 88.94%

Holding current value

$2,969

Previous $25,000 92.0%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.81 - $19.33 $20,770 - $29,072	-1,504 Reduced 88.94%	187 $2,000
Q4 2023 Feb 13, 2024	SELL	$10.87 - $15.93 $94,558 - $138,575	-8,699 Reduced 83.72%	1,691 $25,000
Q3 2023 Nov 14, 2023	BUY	$8.84 - $22.64 $85,624 - $219,291	9,686 Added 1375.85%	10,390 $145,000
Q2 2023 Aug 14, 2023	SELL	$8.75 - $14.29 $9,397 - $15,347	-1,074 Reduced 60.4%	704 $7,000
Q1 2023 May 09, 2023	BUY	$7.99 - $11.02 $295 - $407	37 Added 2.13%	1,778 $16,000

Q4 2022 Feb 10, 2023	SELL	$7.55 - $11.9 $4,809 - $7,580	-637 Reduced 26.79%	1,741 $15,000
Q3 2022 Nov 10, 2022	SELL	$7.21 - $9.41 $973 - $1,270	-135 Reduced 5.37%	2,378 $20,000
Q2 2022 Aug 15, 2022	BUY	$5.12 - $8.74 $7,290 - $12,445	1,424 Added 130.76%	2,513 $21,000
Q1 2022 May 12, 2022	SELL	$5.92 - $9.73 $6,606 - $10,858	-1,116 Reduced 50.61%	1,089 $9,000
Q4 2021 Feb 14, 2022	BUY	$9.03 - $19.13 $14,493 - $30,703	1,605 Added 267.5%	2,205 $21,000
Q3 2021 Nov 15, 2021	SELL	$14.31 - $18.39 $38,551 - $49,542	-2,694 Reduced 81.79%	600 $10,000
Q2 2021 Aug 16, 2021	SELL	$15.2 - $20.94 $19,091 - $26,300	-1,256 Reduced 27.6%	3,294 $50,000
Q1 2021 May 17, 2021	SELL	$17.99 - $26.96 $20,472 - $30,680	-1,138 Reduced 20.01%	4,550 $88,000
Q4 2020 Feb 16, 2021	SELL	$17.54 - $25.43 $270,256 - $391,825	-15,408 Reduced 73.04%	5,688 $103,000
Q3 2020 Nov 16, 2020	BUY	$18.81 - $26.42 $343,527 - $482,508	18,263 Added 644.65%	21,096 $407,000
Q2 2020 Aug 13, 2020	BUY	$16.5 - $29.7 $46,744 - $84,140	2,833 New	2,833 $74,000
Q1 2020 May 15, 2020	SELL	$13.68 - $34.6 $8,153 - $20,621	-596 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$21.11 - $34.86 $29,638 - $48,943	-1,404 Reduced 70.2%	596 $20,000
Q3 2019 Nov 05, 2019	BUY	$23.83 - $36.44 $44,681 - $68,325	1,875 Added 1500.0%	2,000 $47,000
Q2 2019 Aug 13, 2019	SELL	$32.75 - $40.35 $93,468 - $115,158	-2,854 Reduced 95.8%	125 $4,000
Q1 2019 May 14, 2019	BUY	$35.47 - $54.55 $93,498 - $143,793	2,636 Added 768.51%	2,979 $110,000
Q4 2018 Feb 14, 2019	SELL	$38.35 - $50.39 $13,192 - $17,334	-344 Reduced 50.07%	343 $15,000
Q3 2018 Nov 13, 2018	BUY	$41.65 - $51.7 $22,865 - $28,383	549 Added 397.83%	687 $32,000
Q2 2018 Aug 15, 2018	SELL	$48.35 - $65.33 $2,852 - $3,854	-59 Reduced 29.95%	138 $7,000
Q1 2018 May 15, 2018	BUY	$38.64 - $57.54 $7,612 - $11,335	197 New	197 $10,000
Q4 2017 Feb 09, 2018	SELL	$27.28 - $43.26 $8,675 - $13,756	-318 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$17.15 - $32.72 $5,453 - $10,404	318	318 $10,000

Others Institutions Holding URGN

# of Institutions

113

Shares Held

24M

Call Options Held

46.9K

Put Options Held

44.3K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $361M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Uro Gen Pharma Ltd. Transaction History